GSK vs HCA Healthcare

GSK (GSK), health care, and HCA Healthcare (HCA), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.

HCA Healthcare is worth $105.1B on the stock market and GSK $99.1B: HCA Healthcare is valued at 6% more. GSK trades at 17.2 times earnings and HCA Healthcare at 16.7. Over the past year GSK's share price has moved +6.42% and HCA Healthcare's +7.04%.

Key facts

GSK market value
$99.1B
HCA Healthcare market value
$105.1B
GSK P/E
17.2
HCA Healthcare P/E
16.7
GSK revenue
$43.4BFY to 2025-12-31
HCA Healthcare revenue
$75.6BFY to 2025-12-31
Superinvestors holding both
2

Market values as of .

GSK vs HCA Healthcare: every measure side by side
Measure GSK HCA Healthcare
SectorHealth CareHealth Care
Country United Kingdom United States
Fiscal year ends2025-12-312025-12-31
Size
Market cap$99.1Blower$105.1Bhigher
Revenue$43.4Blower$75.6Bhigher
Earnings$7.6Bhigher$6.8Blower
Employees66,841lower230,000higher
Total assets$81.1Bhigher$60.7Blower
Valuation
P/E17.2higher16.7lower
P/S2.3higher1.4lower
P/B——
Dividend yield—0.60%
Profitability
Operating margin24.3%—
Balance sheet
Net assets$21.7Bhigher-$6Blower
Total liabilities$59.9Blower$63.5Bhigher
Total debt$19.2Blower$46.5Bhigher
Cash on hand$4.5Bhigher$1Blower
Price change
Today-1.90%lower-1.67%higher
1 year+6.42%lower+7.04%higher

Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.

Loading the one-year price chart…

Which superinvestors hold them

From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.

Percentages are each holding's share of that investor's reported portfolio (under "Both": GSK / HCA Healthcare). Who owns GSK · Who owns HCA

Further comparisons

Learn

Questions and answers

Which is bigger, GSK or HCA Healthcare?

By market value, HCA Healthcare is the larger: $105.1B against $99.1B for GSK. By revenue in its latest fiscal year, HCA Healthcare is the larger: $75.6B against $43.4B for GSK.

Which has the higher P/E ratio?

GSK: 17.2, against 16.7 for HCA Healthcare. A higher P/E means the market pays more for each dollar of the last twelve months' earnings; on its own it does not say which is the better value.

Which has more debt?

HCA Healthcare: $46.5B, against $19.2B for GSK. Total debt is borrowings at the end of the latest fiscal year, as each company reported it; it is not set against cash here.

Which superinvestors own both GSK and HCA Healthcare?

In their latest 13F filings, Charles Brandes (founder) and Richard Pzena hold both.

Cite this page

Funkfolio, “GSK vs HCA Healthcare”, data as of 17 November 2026. https://funkfolio.com/compare/gsk-vs-hca

Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.